RANDAL J KIRK Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for RANDAL J KIRK.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of RANDAL J KIRK. RANDAL J KIRK is a Director in CLINICAL DATA INC ($NOVI) and a 10% Owner in AmpliPhi Biosciences Corp ($APHB) and a 10% Owner in Fibrocell Science, Inc. ($FCSC) and a 10% Owner in SOLIGENIX, INC. ($DOR) and a 10% Owner in Synthetic Biologics, Inc. ($SYN) and a 10% Owner in TRANSGENOMIC INC ($TBIO) and a Director in ZIOPHARM ONCOLOGY INC ($ZIOP) and a 10% Owner in HALOZYME THERAPEUTICS INC ($GYHT) and a Director in HALOZYME THERAPEUTICS INC ($GYHT) and a 10% Owner in ORAGENICS INC ($OGEN) and a 10% Owner in INTREXON CORP ($XON) and an Chief Executive Officer in INTREXON CORP ($XON) and a Director in INTREXON CORP ($XON) and an Executive Chairman in INTREXON CORP ($XON) and a 10% Owner in HISTOGENICS CORP ($HSGX) and a 10% Owner in AquaBounty Technologies, Inc. ($AQB).

Over the past year RANDAL J KIRK has been an insider in 3 companies. The total value of shares held by RANDAL J KIRK in these companies amounts to $396,836,954.

RANDAL J KIRK 10% Owner
AquaBounty Technologies, Inc.
10% Owner
Armata Pharmaceuticals, Inc.
Director
CLINICAL DATA INC
10% Owner
Fibrocell Science, Inc.
10% Owner, Director
HALOZYME THERAPEUTICS, INC.
10% Owner
Ocugen, Inc.
10% Owner
ORAGENICS INC
Executive Chairman, Chief Executive Officer, Director, 10% Owner
PRECIGEN, INC.
10% Owner
Precipio, Inc.
10% Owner
SOLIGENIX, INC.
10% Owner
Synthetic Biologics, Inc.
Director
ZIOPHARM ONCOLOGY INC
$ 396836954 The total value of shares held by RANDAL J KIRK
Insider Rank

RANDAL J KIRK ranks 181 out of 350,000 insiders. Go to Insider Ranking to see more.

Address: THIRD SECURITY LLC THE GOVERNOR TYLER RADFORD 24141 VA

Companies in which RANDAL J KIRK is an Insider

AquaBounty Technologies, Inc.

Trading Symbol: AQB
Industry: FISHING, HUNTING & TRAPPING [0900]
Position of RANDAL J KIRK: 10% Owner
Holdings: 8,239,199 shares
Current Value: $129,849,776
Latest Transaction: Oct 29 2018
$AQB Market Capitalization: $88.78M
$AQB Previous Close: $15.76

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 31x
Sell: 2x
Shares Bought: 6,674,365
Shares Sold: 2,115,373
Share Difference: +4,558,992
Value Difference: -$33,086,604

Armata Pharmaceuticals, Inc.

Trading Symbol: APHB
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of RANDAL J KIRK: 10% Owner
Holdings: 802,263 shares
Current Value: $433,222
Latest Transaction: Dec 29 2016
$APHB Market Capitalization: $5.61M
$APHB Previous Close: $0.54

Last 4 weeks trend: BUY
Last 3 months trend: BUY View transactions

Last 3 Months Overview:
Buy: 1x
Sell: 6x
Shares Bought: 428,571
Shares Sold: 177,020
Share Difference: +251,551
Value Difference: +$84,375

CLINICAL DATA INC

Trading Symbol: NOVI
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of RANDAL J KIRK: Director
Holdings: 112,890 shares
Latest Transaction: Nov 13 2003

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Fibrocell Science, Inc.

Trading Symbol: FCSC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of RANDAL J KIRK: 10% Owner
Holdings: 80,160 shares
Current Value: $56,112
Latest Transaction: Dec 17 2019
$FCSC Market Capitalization: $30.78M
$FCSC Previous Close: $0.70

Last 4 weeks trend: BUY
Last 3 months trend: BUY View transactions

Last 3 Months Overview:
Buy: 7x
Sell: 4x
Shares Bought: 3,020,065
Shares Sold: 1,946,278
Share Difference: +1,073,787
Value Difference: +$3,738,834

HALOZYME THERAPEUTICS, INC.

Trading Symbol: GYHT
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of RANDAL J KIRK: 10% Owner, Director
Holdings: 4,120,689 shares
Latest Transaction: Aug 28 2018

Last 4 weeks trend: STRONG SELL
Last 3 months trend: STRONG SELL View transactions

Last 3 Months Overview:
Buy: 19x
Sell: 44x
Shares Bought: 5,418,607
Shares Sold: 11,468,978
Share Difference: -6,050,371
Value Difference: +$66,653,865

Ocugen, Inc.

Trading Symbol: HSGX
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of RANDAL J KIRK: 10% Owner
Holdings: 2,438,770 shares
Current Value: $4,048,358
Latest Transaction: Jan 15 2019
$HSGX Market Capitalization: $28.25M
$HSGX Previous Close: $1.66

Last 4 weeks trend: STRONG SELL
Last 3 months trend: STRONG SELL View transactions

Last 3 Months Overview:
Buy: 0x
Sell: 3x
Shares Bought: 0
Shares Sold: 998,204
Share Difference: -998,204
Value Difference: +$158,772

ORAGENICS INC

Trading Symbol: OGEN
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of RANDAL J KIRK: 10% Owner
Holdings: 14,481,089 shares
Current Value: $11,005,628
Latest Transaction: Jul 05 2016
$OGEN Market Capitalization: $38.33M
$OGEN Previous Close: $0.76

Last 4 weeks trend: BUY
Last 3 months trend: BUY View transactions

Last 3 Months Overview:
Buy: 1x
Sell: 0x
Shares Bought: 2,261,419
Shares Sold: 0
Share Difference: +2,261,419
Value Difference: -$1,166,666

PRECIGEN, INC.

Trading Symbol: XON
Industry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of RANDAL J KIRK: Executive Chairman, Chief Executive Officer, Director, 10% Owner
Holdings: 18,528,842 shares
Current Value: $396,702,507
Latest Transaction: Feb 04 2020
$XON Market Capitalization: $2.53B
$XON Previous Close: $21.41

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 371x
Sell: 31x
Shares Bought: 54,488,993
Shares Sold: 29,380,737
Share Difference: +25,108,256
Value Difference: -$249,648,769

Precipio, Inc.

Trading Symbol: TBIO
Industry: LABORATORY ANALYTICAL INSTRUMENTS [3826]
Position of RANDAL J KIRK: 10% Owner
Holdings: 533,809 shares
Current Value: $373,666
Latest Transaction: Aug 30 2018
$TBIO Market Capitalization: $16.73M
$TBIO Previous Close: $0.70

Last 4 weeks trend: STRONG SELL
Last 3 months trend: STRONG SELL View transactions

Last 3 Months Overview:
Buy: 10x
Sell: 12x
Shares Bought: 1,173,267
Shares Sold: 2,024,200
Share Difference: -850,933
Value Difference: -$3,294,278

SOLIGENIX, INC.

Trading Symbol: SNGX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of RANDAL J KIRK: 10% Owner
Holdings: 583,334 shares
Latest Transaction: May 08 2017

Last 4 weeks trend: BUY
Last 3 months trend: BUY View transactions

Last 3 Months Overview:
Buy: 1x
Sell: 7x
Shares Bought: 250,000
Shares Sold: 160,968
Share Difference: +89,032
Value Difference: +$301,882

Synthetic Biologics, Inc.

Trading Symbol: SYN
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of RANDAL J KIRK: 10% Owner
Holdings: 92,159 shares
Current Value: $78,335
Latest Transaction: Apr 03 2019
$SYN Market Capitalization: $76.50M
$SYN Previous Close: $0.85

Last 4 weeks trend: STRONG SELL
Last 3 months trend: STRONG SELL View transactions

Last 3 Months Overview:
Buy: 0x
Sell: 6x
Shares Bought: 0
Shares Sold: 150,565
Share Difference: -150,565
Value Difference: +$98,837

ZIOPHARM ONCOLOGY INC

Trading Symbol: ZIOP
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of RANDAL J KIRK: Director
Holdings: 139,513 shares
Current Value: $934,737
Latest Transaction: Oct 09 2018
$ZIOP Market Capitalization: $850.83M
$ZIOP Previous Close: $6.70

Last 4 weeks trend: BUY
Last 3 months trend: BUY View transactions

Last 3 Months Overview:
Buy: 1x
Sell: 0x
Shares Bought: 17,204
Shares Sold: 0
Share Difference: +17,204
Value Difference: $0

Latest Insider Trading Transactions of RANDAL J KIRK

Sentiment: All, AQB, APHB, NOVI, FCSC, GYHT, HSGX, OGEN, XON, TBIO, SNGX, SYN, ZIOP

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Feb 04 2020XONPRECIGEN, INC.KIRK RANDAL JExecutive ChairmanBuyP5.8624,787145,252182,200157.4 K to 182.2 K (+15.75 %)
Feb 04 2020XONPRECIGEN, INC.KIRK RANDAL JExecutive ChairmanBuyP5.8629,684173,948151,802122.1 K to 151.8 K (+24.31 %)
Feb 04 2020XONPRECIGEN, INC.KIRK RANDAL JExecutive ChairmanBuyP5.86160,606941,151337,234176.6 K to 337.2 K (+90.93 %)
Feb 04 2020XONPRECIGEN, INC.KIRK RANDAL JExecutive ChairmanBuyP5.86133,370781,5481,299,2671.2 M to 1.3 M (+11.44 %)
Feb 04 2020XONPRECIGEN, INC.KIRK RANDAL JExecutive ChairmanBuyP5.86454,6422,664,2021,832,0541.4 M to 1.8 M (+33.01 %)
Feb 04 2020XONPRECIGEN, INC.KIRK RANDAL JExecutive ChairmanBuyP5.86160,785942,200366,548205.8 K to 366.5 K (+78.14 %)
Feb 04 2020XONPRECIGEN, INC.KIRK RANDAL JExecutive ChairmanBuyP5.86250,6741,468,9501,316,7981.1 M to 1.3 M (+23.51 %)

View all RANDAL J KIRK insider transactions.